Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,000 shares at $675.00 ($1.4M) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $1.4M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2024-01-04 | $1.0M | — | Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2021-09-15 | $650K | — | Filing → |